首页> 外国专利> PHARMACEUTICAL COMPOSITION CONTAINING (R)-3-N,N-DICYKLOBUTYLAMINO-8-FLUORO-3,4-DIHYDRO-2H-1-BENZOPYRAN-5-CARBOXAMIDE HIDROGEN-(2R,3R)TARTARATE MONOHYDRATE AND PAROXETIN AND PROCESS FOR ITS PREPARATION

PHARMACEUTICAL COMPOSITION CONTAINING (R)-3-N,N-DICYKLOBUTYLAMINO-8-FLUORO-3,4-DIHYDRO-2H-1-BENZOPYRAN-5-CARBOXAMIDE HIDROGEN-(2R,3R)TARTARATE MONOHYDRATE AND PAROXETIN AND PROCESS FOR ITS PREPARATION

机译:包含(R)-3-N,N-二环戊基氨基-8-氟-3,4-二氢-2H-1-苯并吡喃-5-甲酰胺氢-(2R,3R)酒石酸一水合物和对乙酰氨基酚的药物组合物及其制备方法

摘要

The invention relates to a composition comprising a first component (a) which is (R)-3-N,N-dicyclobutylamino-8-fluoro-3,4-dihydro-2H-1-benzopyran-5-carboxamide hydrogen (2R,3R)-tartrate monohydrate and a second component (b) which is paroxetine in the form of its free base, or a pharmaceutically acceptable salt and/or solvate thereof, the preparation thereof, pharmaceutical formulations containing said composition, use of and a method of treatment of affective disorders such as mood disorders and anxiety disorders with said composition as well as a kit containing said composition.
机译:本发明涉及包含第一组分(a)的组合物,所述第一组分为(R)-3-N,N-二环丁基氨基-8-氟-3,4-二氢-2H-1-苯并吡喃-5-羧酰胺氢(2R, 3R)-酒石酸一水合物和其游离碱形式的帕罗西汀的第二组分(b)或其药学上可接受的盐和/或溶剂化物,其制剂,含有所述组合物的药物制剂,其用途和方法用所述组合物以及包含所述组合物的试剂盒来治疗诸如情绪障碍和焦虑症的情感障碍。

著录项

  • 公开/公告号HU0103544A3

    专利类型

  • 公开/公告日2003-12-29

    原文格式PDF

  • 申请/专利权人 ASTRAZENECA AB SOEDERTALJE;

    申请/专利号HU20010003544

  • 发明设计人

    申请日1999-09-13

  • 分类号A61K31/35;

  • 国家 HU

  • 入库时间 2022-08-21 23:10:59

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号